Detalhe da pesquisa
1.
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
Cell
; 184(7): 1821-1835.e16, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33667349
2.
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants.
Nature
; 600(7889): 530-535, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670266
3.
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody.
Proc Natl Acad Sci U S A
; 119(20): e2120976119, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549549
4.
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
Proc Natl Acad Sci U S A
; 118(36)2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34417349
5.
Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells.
J Immunol Methods
; 524: 113588, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38040193
6.
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy.
J Clin Virol
; 173: 105661, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503118
7.
Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody.
bioRxiv
; 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293237
8.
mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5.
Nat Commun
; 14(1): 1734, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36977711
9.
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection.
Front Public Health
; 11: 1195674, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37415699
10.
B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response.
Nat Commun
; 14(1): 53, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599850
11.
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations.
Commun Biol
; 5(1): 903, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056181
12.
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees.
Hum Vaccin Immunother
; 18(6): 2129196, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269939
13.
Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection.
Nat Commun
; 13(1): 2263, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477725
14.
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees.
Nat Commun
; 13(1): 3375, 2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697673
15.
Pathogenic signature of invasive non-typhoidal Salmonella in Africa: implications for vaccine development.
Hum Vaccin Immunother
; 16(9): 2056-2071, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32692622
16.
SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma.
bioRxiv
; 2020 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33398278
17.
An unwanted guest: Neisseria meningitidis - carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence.
Expert Rev Anti Infect Ther
; 15(7): 689-701, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28524748
18.
N. meningitidis and TLR Polymorphisms: A Fascinating Immunomodulatory Network.
Vaccines (Basel)
; 4(2)2016 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27240411
19.
Fighting Neisseria meningitidis: past and current vaccination strategies.
Expert Rev Vaccines
; 15(11): 1393-1407, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27158988
20.
Neisseria meningitidis infection: who, when and where?
Expert Rev Anti Infect Ther
; 13(10): 1249-63, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26190347